Tag Archives: This

Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year

A few short months after Charles River Laboratories acquired Cognate BioServices, the company is folding yet another CDMO into its cell and gene network, signing more than $ 1 billion in M&A outlays so far this year.  Charles River Laboratories has inked a deal to pay $ 292.5 million in cash for gene therapy CDMO Vigene Biosciences,… Read More »

ICUs are nearing capacity in this French city. And it’s only September

That’s how Dr. Olivier Joannes-Boyau, head of the intensive care unit at University Hospital in the southwestern city of Bordeaux, describes the resurgence of Covid-19 in France. After young French people took advantage of the lifting of lockdown and summer months to socialize freely, Covid-19 hospitalizations have risen in large cities like Paris, Bordeaux and… Read More »

Preeclampsia: Everything You Need to Know about This High-Risk Pregnancy Complication

Although it’s relatively uncommon, affecting just 3.4 percent of pregnancies in the U.S. each year, preeclampsia is a complication that can have serious long-term health effects for mom and baby. The condition is characterized primarily by higher-than-normal blood pressure during pregnancy, and may also involve elevated levels of protein in urine and a decrease in… Read More »